Evaluation of the facioscapulohumeral muscular dystrophy (FSHD1) phenotype in correlation to the concurrence of 4q35 and 10q26 fragments

@article{Khler1999EvaluationOT,
  title={Evaluation of the facioscapulohumeral muscular dystrophy (FSHD1) phenotype in correlation to the concurrence of 4q35 and 10q26 fragments},
  author={J. K{\"o}hler and D. R{\"o}hrig and K. D. Bathke and M. Koch},
  journal={Clinical Genetics},
  year={1999},
  volume={55}
}
Probe p13E‐11 (locus D4F104S1) detects two highly homologous polymorphic loci on chromosomes 4q35 and 10q26. Previous reports in the literature have described a correlation of shortened 4q35‐specific fragments and facioscapulohumeral muscular dystrophy (FSHD1). We have identified 30 FSHD1 families (46 patients) carrying one short 4q35 and one short 10q26 fragment. The clinical data of these patients were compared with those of 47 families (131 patients) showing a single short 4q35 fragment, in… Expand
View on Wiley
ncbi.nlm.nih.gov
15 Citations
Background Citations
4

15 Citations

Citation Type

Citation Type

Facioscapulohumeral muscular dystrophy with EcoRI/BlnI fragment size of more than 32 kb
  • 10
An inherited 4q35-EcoRI-DNA-fragment of 35 kb in a family with a sporadic case of facioscapulohumeral muscular dystrophy (FSHD)
  • 11
Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy
  • 78
  • PDF
Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy ReportoftheGuidelineDevelopment,Dissemination,andImplementationSubcommitteeofthe American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromu
Role of EMG in the evaluation of presumed myopathies in the era of DNA analysis.
  • B. Darras
  • Medicine
  • Supplements to Clinical neurophysiology
  • 2000
  • 1
Chronic Myopathy Associated With Anti–Signal Recognition Particle Antibodies Can Be Misdiagnosed As Facioscapulohumeral Muscular Dystrophy
  • 13
MUSCULAR DYSTROPHIES
Diagnosis of pediatric neuromuscular disorders in the era of DNA analysis.
  • 37
CALCYON gene variation, schizophrenia, and cocaine dependence
  • Xingguang Luo, H. Kranzler, +6 authors J. Gelernter
  • Biology, Medicine
  • American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2004
  • 11
Chapter 14 – Neonatal Hypotonia and Neuromuscular Disorders
...
1
2
...

References

SHOWING 1-10 OF 30 REFERENCES
Epilepsy and mental retardation in a subset of early onset 4q35‐facioscapulohumeral muscular dystrophy
  • 91
Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD.
  • 63
  • PDF
High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families.
  • 102
Germline mosaicism in 4q35 facioscapulohumeral muscular dystrophy (FSHD1A) occurring predominantly in oogenesis
  • 44
The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females.
  • 108
De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1).
  • 28
  • PDF
The FSHD‐linked locus D4F104S1 (p13E‐11) ON 4q35 has a homologue on 10qter
  • 110
  • PDF
Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD).
  • 133
  • PDF
Evidence for anticipation and association of deletion size with severity in facioscapulohumerd muscular dystrophy
  • 159
  • Highly Influential
Facioscapulohumeral dystrophy: A distinct regional myopathy with a novel molecular pathogenesis
  • 108
...
1
2
3
...